Figure 2. Summary of the effects of Psf2MO injection on eye development. Shading depicted in the key indicates categories of normal, minor, and severe eye defect phenotypes (see text for explicit definitions). A: Uninjected control embryos and those injected with the control morpholino (CONMO) exhibited minimal affects. B: Embryos injected with lissamine-tagged Psf2MO exhibit dose dependant eye defects. Note the increasing number and severity of eye defects with increasing doses of Psf2MO. C: Embryos co-injected with Psf2MO and altPsf2 RNA exhibit a dose dependent reduction in eye defects. Error bars indicate standard error.